Found: 69
Select item for more details and to access through your institution.
Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 52, p. 18999, doi. 10.1002/ange.201909857
- By:
- Publication type:
- Article
Immunotherapy and Combination Strategies in Pancreatic Cancer: Current Status and Emerging Trends.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 5, p. 286, doi. 10.1159/000488917
- By:
- Publication type:
- Article
Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 10, p. 1420, doi. 10.3390/cells12101420
- By:
- Publication type:
- Article
Proton Irradiation Increases the Necessity for Homologous Recombination Repair Along with the Indispensability of Non-Homologous End Joining.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 4, p. 889, doi. 10.3390/cells9040889
- By:
- Publication type:
- Article
Knockdown of myeloid cell hypoxia-inducible factor-1α ameliorates the acute pathology in DSS-induced colitis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0190074
- By:
- Publication type:
- Article
Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 5, p. 1268, doi. 10.1007/s12094-023-03323-1
- By:
- Publication type:
- Article
Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 13, p. 6727, doi. 10.3390/ijms22136727
- By:
- Publication type:
- Article
[<sup>68</sup>Ga]Ga-FAPI versus 2-[<sup>18</sup>F]FDG PET/CT in patients with autoimmune thyroiditis: a case control study.
- Published in:
- EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-024-01129-y
- By:
- Publication type:
- Article
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM) Methodology—A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer.
- Published in:
- Current Oncology, 2023, v. 30, n. 6, p. 5828, doi. 10.3390/curroncol30060436
- By:
- Publication type:
- Article
Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 11, p. 1, doi. 10.1002/ctm2.1090
- By:
- Publication type:
- Article
MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells In Vitro and In Vivo.
- Published in:
- Stem Cells International, 2019, p. 1, doi. 10.1155/2019/8475389
- By:
- Publication type:
- Article
Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity.
- Published in:
- Angewandte Chemie International Edition, 2019, v. 58, n. 52, p. 18823, doi. 10.1002/anie.201909857
- By:
- Publication type:
- Article
Expression and Clinicopathological Significance of Notch Signaling and Cell-Fate Genes in Biliary Tract Cancer.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2012, v. 107, n. 1, p. 126, doi. 10.1038/ajg.2011.305
- By:
- Publication type:
- Article
5-ASA Therapy and Renal Function in Inflammatory Bowel Disease.
- Published in:
- 2005
- By:
- Publication type:
- Letter
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267248
- By:
- Publication type:
- Article
Prognostic Implications of <sup>68</sup>Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266981
- By:
- Publication type:
- Article
Histology-Based Radiomics for [<sup>18</sup>F]FDG PET Identifies Tissue Heterogeneity in Pancreatic Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266262
- By:
- Publication type:
- Article
Histology-Based Radiomics for [<sup>18</sup>F]FDG PET Identifies Tissue Heterogeneity in Pancreatic Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 7, p. 1151, doi. 10.2967/jnumed.123.266262
- By:
- Publication type:
- Article
Prognostic Implications of <sup>68</sup>Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 7, p. 1027, doi. 10.2967/jnumed.123.266981
- By:
- Publication type:
- Article
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 6, p. 880, doi. 10.2967/jnumed.123.267248
- By:
- Publication type:
- Article
<sup>68</sup>Ga-Labeled Fibroblast Activation Protein Inhibitor (<sup>68</sup>Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the 68Ga-FAPI PET Observational Trial.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1910, doi. 10.2967/jnumed.122.264827
- By:
- Publication type:
- Article
Superior Tumor Detection for <sup>68</sup>Ga-FAPI-46 Versus <sup>18</sup>F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 7, p. 1049, doi. 10.2967/jnumed.122.265215
- By:
- Publication type:
- Article
Initial clinical experience with <sup>90</sup>Y-FAPI-46 radioligand therapy for advanced stage solid tumors: a case series of nine patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262468
- By:
- Publication type:
- Article
Initial clinical experience with 90Y-FAPI-46 radioligand therapy for advanced stage solid tumors: a case series of nine patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262468
- By:
- Publication type:
- Article
Initial clinical experience with <sup>90</sup>Y-FAPI-46 radioligand therapy for advanced stage solid tumors: a case series of nine patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262468
- By:
- Publication type:
- Article
Initial clinical experience with <sup>90</sup>Y-FAPI-46 radioligand therapy for advanced stage solid tumors: a case series of nine patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262468
- By:
- Publication type:
- Article
Fibroblast-Activating Protein: Targeting the Roots of the Tumor Microenvironment.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 9, p. 1412, doi. 10.2967/jnumed.118.214361
- By:
- Publication type:
- Article
Multimodal Molecular Imaging of Integrin α<sub>v</sub>β<sub>3</sub> for In Vivo Detection of Pancreatic Cancer.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 3, p. 446, doi. 10.2967/jnumed.113.129619
- By:
- Publication type:
- Article
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4315, doi. 10.1007/s00432-022-04314-5
- By:
- Publication type:
- Article
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 3513, doi. 10.1007/s00432-022-04050-w
- By:
- Publication type:
- Article
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 553, doi. 10.1093/oncolo/oyad022
- By:
- Publication type:
- Article
Mir34a constrains pancreatic carcinogenesis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-66561-1
- By:
- Publication type:
- Article
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-64040-1
- By:
- Publication type:
- Article
Cellular model system to dissect the isoform-selectivity of Akt inhibitors.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25512-8
- By:
- Publication type:
- Article
Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23995-z
- By:
- Publication type:
- Article
The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 15, p. 2180, doi. 10.1111/1759-7714.14540
- By:
- Publication type:
- Article
X-Ray Phase-Contrast CT of a Pancreatic Ductal Adenocarcinoma Mouse Model.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058439
- By:
- Publication type:
- Article
MALDI Imaging Mass Spectrometry for In Situ Proteomic Analysis of Preneoplastic Lesions in Pancreatic Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0039424
- By:
- Publication type:
- Article
Identification of Epidermal Pdx1 Expression Discloses Different Roles of Notch1 and Notch2 in Murine Kras<sup>G12D</sup>-Induced Skin Carcinogenesis In Vivo.
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013578
- By:
- Publication type:
- Article
Localized Angiosarcoma, Not One Disease: A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and Etiology.
- Published in:
- Sarcoma, 2021, p. 1, doi. 10.1155/2021/9960085
- By:
- Publication type:
- Article
Dose‐dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL::AF9‐induced leukaemic cells.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 5, p. 1033, doi. 10.1111/bjh.18939
- By:
- Publication type:
- Article
Multimodale Therapie ampullärer Karzinome.
- Published in:
- Der Chirurg, 2021, v. 92, n. 9, p. 803, doi. 10.1007/s00104-021-01454-1
- By:
- Publication type:
- Article
IKKα controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression.
- Published in:
- EMBO Journal, 2006, v. 25, n. 16, p. 3801, doi. 10.1038/sj.emboj.7601259
- By:
- Publication type:
- Article
SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01734-w
- By:
- Publication type:
- Article
Lineage fate of ductular reactions in liver injury and carcinogenesis.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 6, p. 2445, doi. 10.1172/JCI78585
- By:
- Publication type:
- Article
Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner.
- Published in:
- Nucleic Acids Research, 2017, v. 45, n. 11, p. 6334, doi. 10.1093/nar/gkx212
- By:
- Publication type:
- Article
Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation.
- Published in:
- Clinical Epigenetics, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13148-024-01623-z
- By:
- Publication type:
- Article
pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial.
- Published in:
- Clinical Chemistry, 2020, v. 66, n. 12, p. 1510, doi. 10.1093/clinchem/hvaa223
- By:
- Publication type:
- Article
Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascularization.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 50, n. 1, p. 115, doi. 10.1007/s00259-022-05930-6
- By:
- Publication type:
- Article